Patent US5688237A successfully refreshed from Google Patents.
US5688237A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable catheter and method of use
Assignee: Cedars-Sinai Medical Center
•
Filing: 1995-05-04
•
Granted: 1997-11-18
•
Expires: 2015-05-04
Abstract
Abstract An implantable catheter comprises a flexible elongated catheter body having an inflatable balloon positioned near its distal end. At least one distal delivery port is located distal of the balloon and at least one proximal delivery port is located proximal of the balloon. The balloon and the distal and proximal delivery ports are connected in fluid communication with individual lumens. The lumen connected to the balloon is connected to a balloon inflation port at the proximal end of the catheter. The lumens connected to the distal and proximal delivery ports are connected to distal and proximal injection ports. Preferably, the balloon inflation port and the distal and proximal injection ports are all built into an integrated port assembly adapted for implantation under the skin of a medical patient. In use, the distal end of the catheter is inserted and fed into a passageway such as a blood vessel until the balloon and delivery ports lie within a region of interest. The port assembly is then implanted under the patient's skin. Once in place, the balloon can be inflated to occlude the flow of fluid through the passageway, and therapeutic agents can be delivered either distal or proximal of the balloon by injection into the appropriate injection port. It is believed that the catheter is particularly suited to the delivery of hepatocytes and an anticoagulant during a course of cell therapy directed to a patient's liver.
Inventors
- 👤 Jacek Rozga
- 👤 Achilles A. Demetriou
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 20:08
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/0067; A61M25/0068; A61M25/007; A61M25/10
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
180 words
A method of using an implantable catheter to treat a localized region within the body of a patient, the catheter including a flexible elongated catheter body and an inflatable balloon located on the catheter body between the proximal and distal ends of the catheter body, the catheter body having a balloon inflation lumen and first and second delivery lumens, and an implantable integrated port assembly having a balloon inflation port, a distal injection port, and a proximal injection port, each of these ports having an upper surface made of flexible, self-sealing material configured for penetration by the syringe after implantation of the catheter into the body, the method comprising: (a) inserting the balloon and the catheter body from its distal end into a region of interest in the body; (b) inserting the port assembly under the skin of the body; (c) inflating the balloon by injecting fluid into the balloon inflation port; (d) conducting hepatocytes into the region of interest through the distal delivery port; and (e) conducting an anticoagulant into the region of interest through the proximal delivery port.
Claim 2
Independent Claim
180 words
A method of using an implantable catheter to treat a localized region within the body of a patient, the catheter including a flexible elongated catheter body and an inflatable balloon located on the catheter body between the proximal and distal ends of the catheter body, the catheter body having a balloon inflation lumen and first and second delivery lumens, and an implantable integrated port assembly having a balloon inflation port, a distal injection port, and a proximal injection port, each of these ports having an upper surface made of flexible, self-sealing material configured for penetration by the syringe after implantation of the catheter into the body, the method comprising: (a) inserting the balloon and the catheter body from its distal end into a region of interest in the body; (b) inserting the port assembly under the skin of the body; (c) inflating the balloon by injecting fluid into the balloon inflation port; (d) conducting hepatocytes into the region of interest through the distal delivery port; and (e) conducting an anticoagulant into the region of interest through the proximal delivery port.
Claim 3
Dependent Claim
19 words
A method according to claim 1, wherein the conducting of the anticoagulant occurs after the conducting of the hepatocytes.
Claim 4
Dependent Claim
188 words
An implantable catheter for delivering therapeutic agents to a localized region within a body, the agents delivered to the catheter by a syringe extending through the skin of the body, the catheter comprising: a flexible elongated catheter body; an inflatable balloon located on the catheter body; and wherein the catheter body has a proximal end and a distal end, the proximal end including an implantable integrated port assembly having a balloon inflation port, a distal injection port, and a proximal injection port, each of these ports having an upper surface made of flexible, self-sealing material for penetration by the syringe after implantation of the catheter into the body; and the distal end including (a) a balloon inflation lumen in fluid communication with the balloon and the balloon inflation port, (b) a first delivery lumen defining a distal delivery port situated distal to the balloon and through which a first therapeutic agent is delivered from the distal injection port, and (c) a second delivery lumen defining a proximal delivery port situated proximal to the balloon and through which a second therapeutic agent is delivered from the proximal injection port.
Claim 5
Dependent Claim
188 words
An implantable catheter for delivering therapeutic agents to a localized region within a body, the agents delivered to the catheter by a syringe extending through the skin of the body, the catheter comprising: a flexible elongated catheter body; an inflatable balloon located on the catheter body; and wherein the catheter body has a proximal end and a distal end, the proximal end including an implantable integrated port assembly having a balloon inflation port, a distal injection port, and a proximal injection port, each of these ports having an upper surface made of flexible, self-sealing material for penetration by the syringe after implantation of the catheter into the body; and the distal end including (a) a balloon inflation lumen in fluid communication with the balloon and the balloon inflation port, (b) a first delivery lumen defining a distal delivery port situated distal to the balloon and through which a first therapeutic agent is delivered from the distal injection port, and (c) a second delivery lumen defining a proximal delivery port situated proximal to the balloon and through which a second therapeutic agent is delivered from the proximal injection port.
Claim 6
Dependent Claim
20 words
A catheter according to claim 3, wherein one injection port defines a rounded interior surface substantially devoid of sharp corners.
Claim 7
Dependent Claim
26 words
A catheter according to claim 1, wherein the injection port that defines a rounded interior surface substantially devoid of sharp corners is the distal injection port.
Claim 8
Dependent Claim
40 words
A catheter according to claim 3, wherein: the first delivery lumen defines a plurality of distal delivery ports situated distal to the balloon; and the second delivery lumen defines a plurality of proximal delivery ports situated proximal to the balloon.
Claim 9
Dependent Claim
19 words
A catheter according to claim 3, wherein a part of the catheter body is made of a radiopaque material.
Claim 10
Dependent Claim
36 words
A catheter according to claim 3, wherein the ports on the proximal end each include lower backing surfaces made of a rigid material adapted to prevent accidental penetration of the syringe needle through the port assembly.
Claim 11
Dependent Claim
25 words
A catheter according to claim 3, wherein the port assembly defines one or more apertures that anchor the port assembly to tissue inside the body.
References Cited (Backward Citations)
DE2737855A1
Cited
US4588394A
Cited
US4692146A
Cited
US4673394A
Cited
US5009234A
Cited
US4911717A
Cited
US5084015A
Cited
US5516336A
Cited
US5085644A
Cited
US5143062A
Cited
US5339808A
Cited
US5314471A
Cited
US5498539A
Cited
US5336178A
Cited
US5300048A
Cited
US5425714A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-11-17 | 2001-05-19 | 2001-11-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-11-17 | 2005-05-19 | 2005-11-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-11-17 | 2009-05-19 | 2009-11-18 | $7700.00 | Window Closed / Lapsed |